NASDAQ:IBB - iShares NASDAQ Biotechnology Index Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $117.91 +0.42 (+0.36 %) (As of 07/17/2018 11:18 AM ET)Previous Close$116.67Today's Range$116.67 - $118.1752-Week Range$100.22 - $119.30Volume30,843 shsAverage Volume2.69 million shsMarket Capitalization$9.70 billionP/E RatioN/ADividend Yield0.27%Beta1.33 Company ProfileFinancialsDividend HistoryHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc. Receive IBB News and Ratings via Email Sign-up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter. Basic Details Issuer Blackrock Fund NameiShares Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology TR USD CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$8.90 billion Average Daily Volume$2.74 million Discount/Premium-1.41% ETF Expenses Management Fee0.47% Other Expenses0.00% Total Expenses0.47% Fee Waiver0.00% Net Expenses0.47%Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial iShares NASDAQ Biotechnology Index (NASDAQ:IBB) Frequently Asked Questions What is iShares NASDAQ Biotechnology Index's stock symbol? iShares NASDAQ Biotechnology Index trades on the NASDAQ under the ticker symbol "IBB." How often does iShares NASDAQ Biotechnology Index pay dividends? What is the dividend yield for iShares NASDAQ Biotechnology Index? iShares NASDAQ Biotechnology Index announced a quarterly dividend on Tuesday, June 26th. Stockholders of record on Wednesday, June 27th will be given a dividend of $0.1561 per share on Monday, July 2nd. This represents a $0.62 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend is Tuesday, June 26th. This is an increase from iShares NASDAQ Biotechnology Index's previous quarterly dividend of $0.13. View iShares NASDAQ Biotechnology Index's Dividend History. When did iShares NASDAQ Biotechnology Index's stock split? How did iShares NASDAQ Biotechnology Index's stock split work? iShares NASDAQ Biotechnology Index's stock split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares NASDAQ Biotechnology Index stock prior to the split would have 300 shares after the split. What is the consensus analysts' recommendation for iShares NASDAQ Biotechnology Index? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iShares NASDAQ Biotechnology Index in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of iShares NASDAQ Biotechnology Index's key competitors? Some companies that are related to iShares NASDAQ Biotechnology Index include DNP Select Income Fund Inc. Common Stock (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), Tri-Continental (TY), Gabelli Equity Trust (GAB), Tortoise Energy Infrastructure (TYG), PIMCO Corporate&Income Opportunity Fund (PTY), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Hercules Capital (HTGC), Apollo Investment (AINV), PIMCO High Income Fund (PHK), Boulder Growth & Income Fund Inc common stock (BIF), AllianceBernstein Global Hgh Incm Fd (AWF) and General American Investors (GAM). Who are iShares NASDAQ Biotechnology Index's key executives? iShares NASDAQ Biotechnology Index's management team includes the folowing people: George G. C. Parker Ph.D., Independent Chairman of the Board of TrusteesMichael Arthur Latham, President, TrusteeJack Gee, Chief Financial Officer, TreasurerGeoffrey D. Flynn, Chief Operating Officer, Executive Vice President, Bio & Compensation - Amy Schioldager, Executive Vice PresidentIra P. Shapiro, Vice President, Chief Legal OfficerMatt Tucker, Vice President, Bio & Compensation - Eilleen M. Clavere, SecretaryCecilia H. Herbert, Independent TrusteeCharles A. Hurty, Independent Trustee Has iShares NASDAQ Biotechnology Index been receiving favorable news coverage? Media stories about IBB stock have been trending somewhat positive on Tuesday, Accern Sentiment reports. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. iShares NASDAQ Biotechnology Index earned a media sentiment score of 0.11 on Accern's scale. They also assigned press coverage about the financial services provider an impact score of 44.82 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term. Who are iShares NASDAQ Biotechnology Index's major shareholders? iShares NASDAQ Biotechnology Index's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.36%), Avondale Wealth Management (0.15%), Vigilant Capital Management LLC (0.12%), Private Capital Advisors Inc. (0.10%), Crescent Grove Advisors LLC (0.09%) and Neville Rodie & Shaw Inc. (0.08%). View Institutional Ownership Trends for iShares NASDAQ Biotechnology Index. Which institutional investors are selling iShares NASDAQ Biotechnology Index stock? IBB stock was sold by a variety of institutional investors in the last quarter, including Private Capital Advisors Inc., Avondale Wealth Management, Crescent Grove Advisors LLC, Winfield Associates Inc., Vigilant Capital Management LLC, Neville Rodie & Shaw Inc., Quattro Financial Advisors LLC and Howard Capital Management Inc.. View Insider Buying and Selling for iShares NASDAQ Biotechnology Index. Which institutional investors are buying iShares NASDAQ Biotechnology Index stock? IBB stock was purchased by a variety of institutional investors in the last quarter, including Macguire Cheswick & Tuttle Investment Counsel LLC, Investment House LLC, Bank of Montreal Can, Personal Resources Investment & Strategic Management Inc., Nwam LLC, NN Investment Partners Holdings N.V., Capital Investment Advisors LLC and Hochman Cole Investment Advisors Inc.. View Insider Buying and Selling for iShares NASDAQ Biotechnology Index. How do I buy shares of iShares NASDAQ Biotechnology Index? Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is iShares NASDAQ Biotechnology Index's stock price today? One share of IBB stock can currently be purchased for approximately $117.91. How big of a company is iShares NASDAQ Biotechnology Index? iShares NASDAQ Biotechnology Index has a market capitalization of $9.70 billion. MarketBeat Community Rating for iShares NASDAQ Biotechnology Index (NASDAQ IBB)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 83 (Vote Outperform)Underperform Votes: 80 (Vote Underperform)Total Votes: 163MarketBeat's community ratings are surveys of what our community members think about iShares NASDAQ Biotechnology Index and other stocks. Vote "Outperform" if you believe IBB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: Should I follow buy, hold and sell recommendations?